Technical University Munich
Welcome,         Profile    Billing    Logout  
 1 Trial 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Biberthaler, Peter
BRAINI2ELDER, NCT05425251: BRAINI-2 Elderly Mild TBI European Study

Recruiting
N/A
2850
Europe
GFAP and UCH-L1
Hospital Universitario 12 de Octubre, Technical University of Munich, University Hospital, Grenoble, University Hospital, Clermont-Ferrand, Hospital Vall d'Hebron, BioMérieux, EIT Health
Mild Traumatic Brain Injury
12/24
03/25
BRAINI2, NCT05413499: Blood Biomarkers to Improve Management of Children With Traumatic Brain Injury

Recruiting
N/A
2880
Europe
Biomarkers research
Nantes University Hospital
Traumatic Brain Injury
01/25
04/25
SteroPoly, NCT05794256: Genderspecific Differences in Hormone Levels After Trauma

Recruiting
N/A
100
Europe
No interventions are planned
Technical University of Munich
Polytrauma
01/25
01/26
Reim, Daniel
HOLIPANC, NCT04617457 / 2019-002734-37: Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas

Recruiting
2
150
Europe
nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA), nal-irinotecan (nal-iri), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA), ONIVYDE TM
University of Cologne, Servier
Pancreatic Cancer, Metastasis, Surgery, Oligometastatic Disease
12/24
09/25
Combs, Stefanie
NCT04246684: Short RT Versus RCT,Followed by Chemo.and Organ Preservation for Interm and High-risk Rectal Cancer Patients

Active, not recruiting
3
702
Europe
Oxaliplatin, 85 mg/m2, Control arm, 5FU; 2400 mg/m2, 5-FU, control arm, 5FU, 250 mg/m2, Experimental arm: 5-FU, 5FU, 2400 mg/m2, experimental arm, Oxaliplatin 50 mg/m2, Experimental arm, Folinic Acid, 400 mg/m2, Folinic Acid, Radiotherapy control, 5x5 Gy: 25 Gy, Capecitabine, 1000 mg/m2, Capecitabine, Oxaliplatin 85 mg/m2, radiotherapy experimental, 30 x 1,8 Gy: 54 Gy, Capecitabine, 825 mg/m2, Oxaliplatin, 130 mg/m2, Oxaliplatin
Prof. Dr. med. Claus Rödel
Rectal Cancer Stage III
09/23
09/28

Download Options